West Pharmaceutical Services Inc (WST)

Date: O: H: L: C: Vol:

Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.25%874.50	872.30	844.90	805.00	804.60
Cost Of Revenue	2.95%527.10	543.10	548.50	501.10	510.30
Gross Profit	5.53%347.40	329.20	296.40	303.90	294.30
	4.00%112.90	117.60	99.50	-	-
Selling, General, and Administrative	4.00%112.90	117.60	99.50	-	-
Research and Development	7.11%18.30	19.70	15.80	-	-
Operating Income/Loss	49.30%267.40	179.10	177.10	156.60	167.60
Income/Loss From Equity Method Investments	29.51%4.30	6.10	3.40	3.90	2.10
Income/Loss From Continuing Operations Before Tax	48.64%267.70	180.10	180.10	161.50	171.90
Income Tax Expense/Benefit	80.12%58.00	32.20	44.70	33.30	34.00
	38.96%214.00	154.00	138.80	132.10	140.00
Attributable To Parent	38.96%214.00	154.00	138.80	132.10	140.00
Basic Average Shares	0.56%70.40	70.80	72.00	-	72.20
Diluted Average Shares	0.70%70.80	71.30	72.40	-	72.60
Basic Earnings Per Share	40.09%3.04	2.17	1.93	1.83	1.94
Diluted Earnings Per Share	40.47%3.02	2.15	1.92	1.82	1.92
Common Stock Dividends	0.22	-	0.22	-	0.22